3i Group share price jumps as UK GDP beats forecasts and investors look to Jan 29 update
15 January 2026
1 min read

3i Group share price jumps as UK GDP beats forecasts and investors look to Jan 29 update

London, Jan 15, 2026, 09:26 GMT — Regular session

  • Shares of 3i Group climbed roughly 3.8% in early London trading.
  • UK GDP data exceeded expectations, boosting bets on rate cuts and lifting risk appetite.
  • Investors are focused on 3i’s Q3 update on Jan. 29 for clues on the portfolio and Action.

3i Group (III.L) shares jumped 3.8% to 3,150 pence in early Thursday trading, outperforming the slightly stronger broader market. 1

The move came after UK data revealed the economy expanded more quickly than anticipated in November, easing some immediate recession worries and shifting attention to possible Bank of England rate cuts. “Firms are telling us they’re still cautious about investing and recruiting,” said Stuart Morrison, research manager at the British Chambers of Commerce. 2

Official data revealed a 0.3% GDP increase in November following a 0.1% drop in October. Services and production sectors edged higher, while construction declined. The Office for National Statistics also reported a 0.1% GDP growth over the three months ending in November. 3

Despite a bounce on Thursday, 3i’s shares have been volatile since late 2025 and still trade far below their autumn peak. On Tuesday, the stock closed at 30.63 pounds, roughly 32% below its 52-week high of 44.97 pounds hit on Oct. 27, according to MarketWatch data. 4

Investors often view 3i as a stand-in for European consumer health and private equity valuations, largely because of its heavy exposure to Action, the Dutch discount retailer. In its latest results, 3i reported that Action’s net sales hit 11.23 billion euros over the first nine reporting periods ending in late September. The firm also increased its stake in Action to 62.3%. CEO Simon Borrows noted the group “remain[s] cautious” about putting capital into new deals. 5

Europe’s mood on Thursday gave a lift. The STOXX 600 climbed, with tech stocks driving the rally after robust earnings. Positive UK data also fueled appetite for risk, Reuters reported. 6

The broader macro outlook remains shaky. Anna Leach, chief economist at the Institute of Directors, highlighted softer consumer services output and a sharp drop in construction as key concerns. 7

For 3i, lower discount rates may boost portfolio valuations and ease financing for leveraged deals, though these effects are indirect and take time to materialize. The shares also react to sentiment around unlisted assets, where price discovery remains uncertain.

The downside is clear: if UK growth stalls again or interest rates remain elevated, investors could start doubting private equity valuations and the premium that some listed firms enjoy over net asset value (NAV)—which reflects portfolio value minus debt. Should Action, the main contributor to 3i’s results, face another slowdown, the share price would likely take a hit fast.

3i’s Q3 update drops Jan. 29. Investors will be watching for a new NAV figure and insights on Action’s trading alongside the broader deal landscape. 8

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Experian PLC stock slips again: what to watch before the Jan. 21 trading update
Previous Story

Experian PLC stock slips again: what to watch before the Jan. 21 trading update

IAG stock edges up as Vueling lays out €5 billion Boeing 737 MAX shift and 2035 growth push
Next Story

IAG stock edges up as Vueling lays out €5 billion Boeing 737 MAX shift and 2035 growth push

Go toTop